What are the diagnostic criteria and recommended management for bereavement-related disorder (prolonged grief disorder)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prolonged Grief Disorder: Diagnostic Criteria and Management

Prolonged Grief Disorder (PGD) is characterized by abnormally persistent, pervasive, and disabling grief responses to bereavement, and should be diagnosed using ICD-11 criteria when intense yearning/longing for the deceased or preoccupation with the deceased persists beyond 6 months after loss, accompanied by significant functional impairment 1.

Diagnostic Criteria

The ICD-11 framework provides the most clinically useful diagnostic approach 1, 2:

Core symptoms (must have at least one):

  • Persistent and pervasive longing for the deceased
  • Persistent preoccupation with the deceased

Associated features (require 1-2 of the following for optimal diagnostic accuracy) 3:

  • Significant emotional pain (sadness, guilt, anger, denial, blame)
  • Difficulty accepting the death
  • Feeling that part of oneself has died
  • Difficulty with positive reminiscing
  • Emotional numbness
  • Difficulty engaging with social or other activities

Critical diagnostic requirements:

  • Symptoms persist for at least 6 months after bereavement 1
  • Duration exceeds expected cultural, social, or religious norms
  • Causes significant impairment in personal, family, social, educational, occupational, or other important areas of functioning 1

Diagnostic Performance

The ICD-11 criteria demonstrate superior clinical utility compared to alternative criteria sets, correctly identifying 95.8% of treatment-responsive patients with distressing and impairing grief 2. Requiring only 1-2 associated symptoms optimizes diagnostic accuracy while avoiding unnecessary restrictiveness 3.

Common Diagnostic Pitfalls

  • Over-restrictive criteria: DSM-5 Section III criteria miss 41% of clinically significant cases by requiring too many associated symptoms 2
  • Cultural considerations: Approximately 25% of bereaved individuals cannot determine if their grief exceeds cultural norms, making this requirement potentially problematic 4
  • Time criterion limitations: PGD symptoms are not markedly higher in those bereaved within 6 months, and the 6-month threshold may not align with actual normative expectations 4

Epidemiology and Risk Factors

Prevalence: Approximately 7% of bereaved individuals develop PGD 5

High-risk populations:

  • Those who lost a spouse or child
  • Bereaved by violent or sudden death 2
  • Refugees, migrants, and conflict survivors 6
  • Older adults experiencing multiple losses 7

Management Approach

Screening and Assessment

Use validated screening instruments to identify cases early 5. The Inventory of Complicated Grief (ICG) with a cutoff score ≥30, combined with Work and Social Adjustment Scale ≥20, effectively identifies clinically significant cases 3.

First-Line Treatment

Targeted psychotherapy is the primary evidence-based intervention 5. The most effective approach includes:

  • Complicated Grief Treatment (CGT): A specialized psychotherapy incorporating elements that:
    • Foster resolution of complicating problems
    • Facilitate the natural healing process
    • Address trauma-related symptoms when present
    • Support gradual re-engagement with life activities

This approach is supported by randomized controlled trial data demonstrating efficacy 5.

Pharmacological Considerations

Antidepressant medications may provide adjunctive benefit, particularly when comorbid depression is present 5. However, psychotherapy remains the cornerstone of treatment.

Essential Clinical Actions

  1. Assess for suicide risk - PGD carries increased mortality risk 5
  2. Screen for comorbidities:
    • Major depressive disorder
    • Post-traumatic stress disorder (PTSD)
    • Anxiety disorders 5
  3. Monitor for adverse health outcomes - PGD is associated with significant medical morbidity 5

Treatment Response Monitoring

Patients meeting ICD-11 criteria show consistent treatment response regardless of specific associated symptom profiles, validating the diagnostic approach 2. Treatment should continue until functional impairment resolves and core grief symptoms diminish to manageable levels.

Special Considerations

Older adults require particular attention as they face multiple losses and are at distinct risk for PGD with associated psychological and physical comorbidities 7. Cross-cultural contexts demand awareness that diagnostic criteria are primarily Western-derived, necessitating cultural sensitivity in application 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.